GT200600302A - Agonistas de ppara/y y procesos de preparación - Google Patents

Agonistas de ppara/y y procesos de preparación

Info

Publication number
GT200600302A
GT200600302A GT200600302A GT200600302A GT200600302A GT 200600302 A GT200600302 A GT 200600302A GT 200600302 A GT200600302 A GT 200600302A GT 200600302 A GT200600302 A GT 200600302A GT 200600302 A GT200600302 A GT 200600302A
Authority
GT
Guatemala
Prior art keywords
agonists
ppara
preparation processes
preparation
phenyl
Prior art date
Application number
GT200600302A
Other languages
English (en)
Inventor
Christine E Garrett
Guang-Pei Chen
George Tien-San Lee
Xinglong Jiang
Michael J Girgis
James Anthony Vivelo
Beata Swerydakrawiec
Dimitris Papoutsakis
Piotr Karpinski
Prasad Koteswara Kapa
Ada Skorodinsky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600302A publication Critical patent/GT200600302A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCIÓN PROPORCIONA UN MÉTODO PARA LA PREPARACIÓN DE COMPUESTOS QUE TIENEN LA ESTRUCTURA I, QUE SON AGONISTAS DEL RECEPTOR ACTIVADO POR LOS PROLIFERADORES DE PEROXISOMA (PPAR) ALFA Y GAMMA. DE UNA MANERA MÁS ESPECÍFICA LA INVENCIÓN SE REFIERE A UN NUEVO PROCESO PARA LA PREPARACIÓN DEL ÁCIDO (2R)-2,3-DIHIDRO-1-[[4-[5-METIL-2-[4-(TRIFLUORO-METIL)-FENIL]-4-OXAZOLIL]-METOXI]-FENIL]-SULFONIL]
GT200600302A 2005-07-13 2006-07-10 Agonistas de ppara/y y procesos de preparación GT200600302A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69880105P 2005-07-13 2005-07-13

Publications (1)

Publication Number Publication Date
GT200600302A true GT200600302A (es) 2007-03-19

Family

ID=37637989

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600302A GT200600302A (es) 2005-07-13 2006-07-10 Agonistas de ppara/y y procesos de preparación

Country Status (21)

Country Link
US (1) US20080221336A1 (es)
EP (1) EP1912978A2 (es)
JP (1) JP2009501720A (es)
KR (1) KR20080023253A (es)
CN (1) CN101218233A (es)
AR (1) AR054829A1 (es)
AU (1) AU2006267037A1 (es)
BR (1) BRPI0613436A2 (es)
CA (1) CA2615055A1 (es)
EC (1) ECSP088091A (es)
GT (1) GT200600302A (es)
IL (1) IL188479A0 (es)
MA (1) MA29624B1 (es)
MX (1) MX2008000464A (es)
NO (1) NO20080790L (es)
PE (1) PE20070191A1 (es)
RU (1) RU2008104793A (es)
TN (1) TNSN08011A1 (es)
TW (1) TW200800973A (es)
WO (1) WO2007009080A2 (es)
ZA (1) ZA200800102B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
JP2009501720A (ja) 2009-01-22
US20080221336A1 (en) 2008-09-11
TW200800973A (en) 2008-01-01
WO2007009080A3 (en) 2007-05-31
RU2008104793A (ru) 2009-08-20
WO2007009080A2 (en) 2007-01-18
TNSN08011A1 (en) 2009-07-14
CA2615055A1 (en) 2007-01-18
KR20080023253A (ko) 2008-03-12
ZA200800102B (en) 2009-02-25
CN101218233A (zh) 2008-07-09
BRPI0613436A2 (pt) 2011-01-11
EP1912978A2 (en) 2008-04-23
PE20070191A1 (es) 2007-03-20
MA29624B1 (fr) 2008-07-01
MX2008000464A (es) 2008-03-11
AR054829A1 (es) 2007-07-18
NO20080790L (no) 2008-02-13
ECSP088091A (es) 2008-02-20
IL188479A0 (en) 2008-04-13
AU2006267037A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
CL2018001111A1 (es) Lipidos que contienen azufre para uso en suplementos alimenticios o medicamentos.
ES2526555T3 (es) Composición fungicida y método para controlar enfermedades de plantas
EA201270169A1 (ru) Агонисты gpr119
BRPI0922475A2 (pt) composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
CL2010001366A1 (es) Composicion farmaceutica de liberacion controlada que comprende topiramato, celulosa microcristalina y metilcelulosa; preparado farmaceutico que la comprende, util para tratar la obesidad, diabetes o una afeccion relacionada.
BRPI0814958A2 (pt) Compostos de indazol ou indol, composição, e, método para preparar uma composição.
CR20120296A (es) Nuevos compuestos de espiropiperidina
CL2012001722A1 (es) Compuestos derivados de 3-hidroxi-5-arilisotiazol, agonistas del receptor 40 acoplado a la proteina g (gpr40); composición farmacéutica que los comprende; y método para el tratamiento o la prevención de la diabetes.
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
AR072761A1 (es) Mezcla de fibras pediatrica
BRPI0915382A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou um distúrbio.
CO6531458A2 (es) Nuevos compuestos de espiropiperidina
EA201001402A1 (ru) Фармацевтические растворы, способ получения и терапевтическое применение
CL2009001298A1 (es) Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4.
BRPI0919643A2 (pt) aparelho de formação de imagem de raio-x, e, método para formar imagem de raio-x
CL2014000936A1 (es) Metodo de obtención de plantas madereras usando factores de transcripcion (divisional de la solicitud 3915-08).
BRPI0912539A2 (pt) composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
BRPI0815779A2 (pt) Processo para preparar aminas, usos de um efluente de reação, e de uma monoamina, e, composto.
BRPI0923856A2 (pt) composto, composição farmacêutica, uso de um composto, e método para tratar uma doença ou distúrbio.
CL2007003817A1 (es) Agente terapeutico para la miopatia inflamatoria que comprende un antagonista de interleucina-6 (il-6).
BRPI0919694A2 (pt) composto, composto farmacêutica, uso de um composto, e, método de tratamento de uma doença.
BRPI0903914A2 (pt) Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica.
GT200600302A (es) Agonistas de ppara/y y procesos de preparación
HN2011001773A (es) Compuestos etanaminicos y su uso para tratar la depresion nuevo titulo técnico: compuestos etanamínicos y composición farmacéutica que los contiene para la depresion. (a petición de la oficina)
BRPI0817750A2 (pt) Método para produzir um composto, composição farmacêutica, ativador de glicoquinase, e, agente para tratar diabetes.